In vitro susceptibilities of gram-negative bacteria isolated from hospitalized patients in four European countries, Canada, and the United States in 2000-2001 to expanded-spectrum cephalosporins and comparator antimicrobials: implications for therap

In vitro susceptibilities of gram-negative bacteria isolated from hospitalized patients in four European countries, Canada, and the United States in 2000-2001 to expanded-spectrum cephalosporins and comparator antimicrobials: implications for therap

Item
http://www.wikidata.org/entity/Q39913204
Identification and evolution of drug efflux pump in clinical Enterobacter aerogenes strains isolated in 1995 and 2003Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient.Isolated microorganisms in plastic biliary stents placed for benign and malignant diseases.Using interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureusAntimicrobial activity against gram negative bacilli from Yaounde Central Hospital, CameroonAminoglycoside resistance in Pseudomonas aeruginosa.Mechanisms of resistance to quinolones.Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination.Case-control analysis of endemic Serratia marcescens bacteremia in a neonatal intensive care unit.Effect of generics on price and consumption of ciprofloxacin in primary healthcare: the relationship to increasing resistance.The OPTAMA programme: utilizing MYSTIC (2002) to predict critical pharmacodynamic target attainment against nosocomial pathogens in Europe.Characterization of antimicrobial resistance and quinolone resistance factors in high-level ciprofloxacin-resistant Enterococcus faecalis and Enterococcus faecium isolates obtained from fresh produce and fecal samples of patients.
P2860

In vitro susceptibilities of gram-negative bacteria isolated from hospitalized patients in four European countries, Canada, and the United States in 2000-2001 to expanded-spectrum cephalosporins and comparator antimicrobials: implications for therap

Item
http://www.wikidata.org/entity/Q39913204
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
In vitro susceptibilities of g ...... bials: implications for therap
@en
In vitro susceptibilities of g ...... bials: implications for therap
@nl
type
label
In vitro susceptibilities of g ...... bials: implications for therap
@en
In vitro susceptibilities of g ...... bials: implications for therap
@nl
prefLabel
In vitro susceptibilities of g ...... bials: implications for therap
@en
In vitro susceptibilities of g ...... bials: implications for therap
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
In vitro susceptibilities of g ...... bials: implications for therap
@en
P2093
P2860
P304
P31
P356
10.1128/AAC.47.10.3089-3098.2003
P407
P433
P478
P577
P698
P921
P932